• About
  • Subscribe
  • Advertise
  • Contact
Sunday, July 19, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Backlash over Medibank’s dated cataract surgery comments

by Staff Writer
October 8, 2016
in Products
Reading Time: 3 mins read
A A
Share on FacebookShare on Twitter

In a report in The Australian newspaper dated 8 August, Dr Andrew Wilson, Medibank’s executive general manager of provider networks and integrated care, implied Australian ophthalmologists were charging higher fees for cataract surgery than the US and Europe.The rarks were made as part of a broader commentary on the need for greater transparency within Australia’s health sector as a market failure was supposedly causing costs to rise. The increase in prices cannot be explained by increasing complexity of procedures alone when the cost of a procedure in Australia is more expensive than in other comparable countries, he told the newspaper, adding, [We] are not competitive compared to many other countries. Dr Wilson cited data from the International Federation of Health Plans’ (IFHP) 2013 Comparative Price Report, which stated that the average price of cataract surgery in Australia was US$3,841, higher than the US’ US$3,762 and more than double the Netherlands’ US$1,610.However, several ophthalmology and medical bodies were quick to point out that Dr Wilson had used out-of-date information. I and my RANZCO colleagues are extrely confused by Medibank Private’s statent about the cost of cataract surgery in Australia, especially given that it relies on 2013 data, rather than the updated 2015 data which is available and which shows that cataract surgery in Australia is cheaper than in either the US or the UK, Dr Bradley Horsburgh, president of the Royal Australian and New Zealand College of Ophthalmologists (RANZCO), said. Medibank Private is also very much aware that ophthalmologists’ fees account for less than a third of the cost of cataract surgery. The rest of the fees cover the costs of the intraocular lens, the anaesthetist and the hospital. {{image3-a:r-w:300}}Australian Private Hospitals Association chief executive officer Mr Michael Roff claimed Medibank deliberately chose to use the 2013 data because in that year, the Australian dollar had been extrely strong against the US dollar, causing distortions in the international comparisons. The 2015 report, which Medibank chose to ignore, shows Australia is indeed competitive based on the IFHP analysis and is not the most expensive country on any measure, he said.The 2015 data reportedly showed the average cost for cataract surgery in Australia was 16 per cent lower than the US and lower than the UK. Medibank have been caught out presenting meaningless and out-of-date data and misrepresenting the true picture in order to further their own cause, Mr Roff stated. Australians should certainly be asking questions about healthcare costs, not least of all why large insurers make such significant profits and continue to cry poor. Australian Society of Ophthalmologists (ASO) president Dr Michael Steiner agreed that the unfair attack on medical specialists and the fees they charged had cast doubt on the health fund’s credibility, adding that Medibank had been disingenuous in its attpt to tarnish the reputation of Australian surgeons . This is the insurer who is facing legal action from the ACCC [Australian Competition and Consumer Commission] over alleged misleading and unconscionable conduct, he said. It is also the insurer which, in 2010, decided to restrict cover for cataract surgery for 300,000 of its policy holders. Consumers deserve to have access to healthcare providers who are open and accountable; no doctor will have an argument with that. Medibank’s credibility in this area, however, must be seriously questioned. Australian Medical Association president Dr Michael Gannon denied doctors were forcing costs to increase and instead blamed insurers for forcing more of the expense onto patients and healthcare providers.He said that the real driver behind rising costs was a mix of factors, including the cost of prostheses, rising wages, technological advances, soaring drug prices and an ageing population, which meant that patients were increasingly presenting with a complexity of health probls.Sharing a similar view, Dr Horsburgh said, The increasingly ageing population in Australia means that patients present with more complicated conditions and greater co-morbidities than ever before. Despite that, the data shows that in 2015 the cost of cataract surgery in Australia is less than in the US or the UK.

Related Posts

Flavio Cobolli will be the face of the Polaroid Eyewear global campaigns for the 2026 and 2027 seasons. Image: Polaroid Eyewear.

Tennis player Flavio Cobolli named as Polaroid Eyewear brand ambassador

by Helen Carter
June 18, 2026

Polaroid Eyewear has announced Italian tennis player Flavio Cobolli is its new brand ambassador for 2026 and 2027, strengthening the...

The AI-OCT system delivered a 45% reduction in false-positive referrals for DME without missing any DME cases. Image: Jayk/stock.adobe.com.

AI-OCT system cuts unnecessary diabetic eye referrals in clinical trial

by Helen Carter
June 16, 2026

A new artificial intelligence-powered optical coherence tomography (AI-OCT) system could significantly reduce unnecessary referrals for diabetic macular oedema (DME) while...

The eye drops can quickly relieve tired, red eyes. Image: LimeSky/stock.adobe.com.

B+L announces launch of Lumify eye drops in Australia

by Staff Writer
March 16, 2026

Bausch + Lomb (B+L) has announced the Australian launch of Lumify redness reliever eye drops in April. The Lumify range...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited